Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer
Tài liệu tham khảo
Groopman, 1999, Chemotherapy-induced anemia in adults: incidence and treatment, J. Natl. Cancer Inst., 91, 1616, 10.1093/jnci/91.19.1616
Abels, 1993, Erythropoeitin for anaemia in cancer patients, Eur. J. Cancer, 29A, S2, 10.1016/S0959-8049(05)80281-3
Vansteenkiste, 2002, Double blind, placebo-controlled, randomized phase 3 trial of darbepoetin alfa in lung cancer patients receiving chemotherapy, J. Natl. Cancer Inst., 94, 1211, 10.1093/jnci/94.16.1211
Kurz, 1997, Erythropoeitin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double blind placebo-controlled multicenter study, Gynecol. Oncol., 65, 461, 10.1006/gyno.1997.4675
Jilani, 1998, Impact of epoetin alfa in chemotherapy-associated anemia, Semin. Hematol., 25, 571
Glaspy, 1997, The impact of epoetin alfa on quality of life during cancer chemotherapy: a fresh look at an old problem, Semin. Oncol., 34, 20
Ferrario, 2004, Treatment of cancer-related anemia with epoetin alfa: a review, Cancer Treat. Rev., 30, 563, 10.1016/j.ctrv.2004.04.005
Rosenzweig, 2004, The decision to prematurely terminate a trial of r-HuEPO due to thrombotic events, J. Pain Symptom Manage., 27, 185, 10.1016/j.jpainsymman.2003.06.010
Wun, 2003, Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin, Cancer, 98, 1514, 10.1002/cncr.11700
Procrit® (epoetin alfa) prescribing information. 2004. Available at http://www.orthobiotech.com/common/prescribing_information/PROCRIT/PDF/ProcritBooklet.pdf. Accessed 5 June 2006.
Aranesp® (darbepoetin alfa) prescribing information. 2004. Available at http://www.aranesp.com/pdf/aranesp_PI.pdf. Accessed 5 June 2006.
Besarab, 1998, The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin, N. Engl. J. Med., 339, 584, 10.1056/NEJM199808273390903
